{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-24-000101","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2024-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.988653+00:00","generated_at":"2026-05-28T23:37:21.882827+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Salarius stockholders re-elect directors, approve say-on-pay, ratify auditor at annual meeting","bullets":["Two Class III directors re-elected: Tess Burleson (141,974 for) and Paul Lammers (145,485 for).","Non-binding advisory vote on named executive officer compensation approved (135,949 for, 18,637 against).","Ratification of Ernst & Young LLP as independent auditor for FY 2024 approved (496,239 for, 59,576 against).","Quorum of 39.7% (572,540 of 1,441,157 shares) present at December 20, 2024 meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-24-000101","json":"https://secwatch.observer/filing/0001615219-24-000101.json","markdown":"https://secwatch.observer/filing/0001615219-24-000101.md","text":"https://secwatch.observer/filing/0001615219-24-000101.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521924000101/0001615219-24-000101-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521924000101/flks-20241220.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T23:37:21.882827+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}